Advanced quantitative MRI radiomics features for recurrence prediction in glioblastoma multiform patients

Authors

  • Abbas Haghparast Department of Medical Physics, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Ghasem Hajianfar MSc student of Medical Physics, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Hassan Maleki Department of Biomedical and Health Informatics, Rajaei Cardiovascular, Medical & Research Center, Iran University of Medical Science, Tehran, Iran
  • Isaac shiri Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran Department of Biomedical and Health Informatics, Rajaei Cardiovascular, Medical & Research Center, Iran University of Medical Science, Tehran, Iran
  • Mehrdad Oveisi Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran Department of Computer Science, The University of British Columbia, Vancouver, British Columbia, Canada
Abstract:

Introduction: Advanced quantitative information such as radiomics features derived from magnetic resonance (MR) image may be useful for outcome prediction, prognostic models or response biomarkers in Glioblastoma (GBM). The main aim of this study was to evaluate MRI radiomics features for recurrence prediction in glioblastoma multiform.   Materials and Methods: 86 patients with recurrent GBM who underwent MRI were subjected to this study. The axial T1-weighted contrast-enhanced and axial T2-weighted FLAIR images were included for analysis. All images were preprocessed by different bin width (32, 64 and 128). For each lesion we manually segmented Active, Necrosis and whole Tumor region in T1-CE and Edema region in T2-FLAIR. 105 quantitative 3D features and texture based on intensity histograms (IH), gray level run-length (GLRLM), gray level co-occurrence (GLCM), gray level size-zone texture matrices (GLSZM), neighborhood-difference matrices (NDM), and geometric features were extracted from the 3D-tumor volumes of each segment. Random Forest (RF) machine learning with 10-fold cross validation was used to recurrence prediction in GBM. Results: Area under ROC curve (AUC) as an assessment index on RF with bin width of 32, 64 and 128 achieved in Active (0.616, 0.586, 0.509), Necrosis (0.521, 0.521, 0.545), whole Tumor (0.639, 0.602, 0.547) and Edema regions (0.629, 0.669, 0.621), respectively. Conclusion: The main purpose of this assay was to assess the power of MRI radiomics features in GBM patients for recurrence prediction. The proposed method can effectively predict recurrence in GBM by application of advanced MRI quantitative radiomics features and machine learning.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

test-retest reproducibility and robustness analysis of recurrent glioblastoma mri radiomics texture features

conclusions test-retest and correlation analyses have identified non-redundant radiomics features and this feature are prone to errors if they employed as quantitative biomarker for gbm image analysis. however when we use robust and redundant feature, quantitative image radiomics features are informative and prognostic biomarkers for gbm magnetic resonance imaging. results results shows that th...

full text

Prediction of Glioblastoma Multiform Response to Bevacizumab Treatment Using Multi-Parametric MRI

Glioblastoma multiform (GBM) is a highly malignant brain tumor. Bevacizumab is a recent therapy for stopping tumor growth and even shrinking tumor through inhibition of vascular development (angiogenesis). This paper presents a non-invasive approach based on image analysis of multi-parametric magnetic resonance images (MRI) to predict response of GBM to this treatment. The resulting prediction ...

full text

Advanced nasopharyngeal carcinoma: pre-treatment prediction of progression based on multi-parametric MRI radiomics

We aimed to investigate the potential of radiomic features of magnetic resonance imaging (MRI) to predict progression in patients with advanced nasopharyngeal carcinoma (NPC). One hundred and thirteen consecutive patients (01/2007-07/2013) (training cohort: n = 80; validation cohort: n = 33) with advanced NPC were enrolled. A total of 970 initial features were extracted from T2-weighted (T2-w) ...

full text

Prognosis and Survival Study in Patients with Glioblastoma Multiform and Its Relationship with EGFR Expression

Background and Aim: Glioblastoma multiforme (GBM) is the most common malignant and invasive tumor of the brain. The relation between prognosis and survival of GBM patients with Epidermal Growth Factor Receptor (EGFR) expression is challenging. Thus, we aimed to evaluate the prognosis and survival of patients with GBM and its relationship with EGFR expression. Materials and Methods: This single...

full text

P157: Periostin Recruits Tumor Associated Macrophages in Glioblastoma Multiform

Glioblastoma multiform (GBM) is the most common and lethal type of primary brain tumors with high rates of morbidity and mortality. Treatment options are limited and ineffective in most of the cases. Epidemiological studies have shown a link between inflammation and glioma genesis.  In addition, at the molecular level, pro-inflammatory cytokines released from activated microglia can increa...

full text

A novel tool to analyze MRI recurrence patterns in glioblastoma.

At least 10% of glioblastoma relapses occur at distant and even contralateral locations. This disseminated growth limits surgical intervention and contributes to neurological morbidity. Preclinical data pointed toward a role for temozolomide (TMZ) in reducing radiotherapy-induced glioma cell invasiveness. Our objective was to develop and validate a new analysis tool of MRI data to examine the c...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 15  issue Special Issue-12th. Iranian Congress of Medical Physics

pages  319- 319

publication date 2018-12-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023